News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,118 Results
Type
Article (39812)
Company Profile (247)
Press Release (659059)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204259)
Career Advice (2011)
Deals (35432)
Drug Delivery (95)
Drug Development (81076)
Employer Resources (172)
FDA (16183)
Job Trends (14870)
News (345350)
Policy (32561)
Tag
Academia (2560)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49450)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (124)
Approvals (16188)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11643)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2250)
Cardiovascular disease (173)
Career advice (1679)
Career pathing (30)
CAR-T (150)
Cell therapy (422)
Cervical cancer (19)
Clinical research (66007)
Collaboration (832)
Compensation (524)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2195)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (270)
Diagnostics (6373)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86606)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112422)
Executive appointments (722)
FDA (17429)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (707)
Government (4419)
Grass and pollen (4)
Guidances (59)
Healthcare (18828)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (312)
IPO (16511)
IRA (40)
Job creations (3636)
Job search strategy (1425)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7919)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (66)
Medical device (13383)
Medtech (13388)
Mergers & acquisitions (19464)
Metabolic disorders (682)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1910)
NextGen: Class of 2025 (6517)
Non-profit (4484)
Now hiring (39)
Obesity (362)
Opinion (208)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57352)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20563)
Phase II (29062)
Phase III (21653)
Pipeline (1184)
Policy (138)
Postmarket research (2568)
Preclinical (8740)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5915)
Recruiting (65)
Regulatory (22281)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (29)
Vaccines (685)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (173)
Last 7 days (869)
Last 30 days (2625)
Last 365 days (32825)
2025 (10598)
2024 (35226)
2023 (40092)
2022 (51185)
2021 (55722)
2020 (54099)
2019 (46565)
2018 (35050)
2017 (32126)
2016 (31497)
2015 (37572)
2014 (31338)
2013 (26376)
2012 (28601)
2011 (29296)
2010 (27361)
Location
Africa (722)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37862)
Australia (6194)
California (6101)
Canada (2008)
China (520)
Colorado (266)
Connecticut (272)
Delaware (146)
Europe (81300)
Florida (907)
Georgia (205)
Idaho (57)
Illinois (534)
India (25)
Indiana (306)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (887)
Massachusetts (4550)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1719)
New Mexico (28)
New York (1737)
North Carolina (964)
North Dakota (8)
Northern California (2666)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1371)
Puerto Rico (12)
Rhode Island (33)
South America (1100)
South Carolina (22)
South Dakota (1)
Southern California (2289)
Tennessee (101)
Texas (904)
United States (23018)
Utah (180)
Virginia (144)
Washington D.C. (61)
Washington State (550)
West Virginia (3)
Wisconsin (54)
699,118 Results for "henry schein inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Henry Schein to Present at Investor Conferences in May 2024
Henry Schein, Inc. announced today that the Company will present at the following investor conferences in May.
April 29, 2024
·
2 min read
Deals
Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced it has completed the acquisition of TriMed, Inc., a global developer of solutions for the orthopedic treatment of lower extremities and upper extremities.
April 4, 2024
·
8 min read
Press Releases
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
February 25, 2025
·
20 min read
Pharm Country
Henry Schein Presents THRIVELIVE 2024
Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will host THRIVELIVE™ 2024, the Company’s annual dental event that celebrates innovation and community and provides a one-of-a-kind educational experience for dental professionals to learn how to grow their practices.
April 2, 2024
·
4 min read
Press Releases
Henry Schein to Participate in Investor Conferences in November
October 24, 2024
·
2 min read
Business
Henry Schein Reports Solid First-Quarter 2024 Financial Results and Updates 2024 Financial Guidance
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, reported financial results for the first quarter ended March 30, 2024.
May 7, 2024
·
21 min read
Press Releases
Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products
November 20, 2024
·
8 min read
Pharm Country
Henry Schein Supports The ‘Carry The Load’ Memorial May Campaign For Third Consecutive Year
Henry Schein, Inc. (Nasdaq: HSIC) today announced that for the third consecutive year it is supporting the Carry The Load ® Memorial May campaign, a month-long Memorial Day awareness program providing active ways to connect Americans to the sacrifices made by the U.S. military, veterans.
April 18, 2024
·
5 min read
Press Releases
Henry Schein Reports Third Quarter 2024 Financial Results and Increases 2024 Financial Guidance
November 5, 2024
·
20 min read
Pharm Country
Henry Schein Enters Extremity Segment of Orthopedic Market
Henry Schein, Inc. announced plans to enter the upper- and lower-extremities specialty segment of the orthopedic market in line with our long-standing strategy.
December 20, 2023
·
9 min read
1 of 69,912
Next
